# Backblaze, Inc.: financial statements, quarterly

BLZE · Nasdaq · CIK 1462056 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/blze.md) · [Financials](/companies/blze/financials.md) · [Filings](/companies/blze/filings.md) · [Insiders](/companies/blze/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/blze/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [25.3](/filings/0001462056-24-000053.md) | [28.7 d](/filings/0001628280-26-016395.md) | [30.0](/filings/0001628280-25-023137.md) | [31.3](/filings/0001628280-25-038603.md) | [32.6](/filings/0001628280-25-049877.md) | [33.8 d](/filings/0001628280-26-016395.md) | [34.6](/filings/0001628280-26-029797.md) | [36.3](/filings/0001628280-26-051818.md) | [37.2](/filings/0001628280-25-049877.md) | [37.8 d](/filings/0001628280-26-016395.md) | [38.7](/filings/0001628280-26-029797.md) | [42.7](/filings/0001628280-26-051818.md) |
| Cost of revenue | $m | [13.5](/filings/0001462056-24-000053.md) | [13.7 d](/filings/0001628280-26-016395.md) | [14.2](/filings/0001628280-25-023137.md) | [14.1](/filings/0001628280-25-038603.md) | [14.8](/filings/0001628280-25-049877.md) | [15.3 d](/filings/0001628280-26-016395.md) | [15.4](/filings/0001628280-26-029797.md) | [13.3](/filings/0001628280-26-051818.md) | [14.1](/filings/0001628280-25-049877.md) | [14.3 d](/filings/0001628280-26-016395.md) | [15.1](/filings/0001628280-26-029797.md) | [15.9](/filings/0001628280-26-051818.md) |
| Gross profit | $m | [11.8](/filings/0001462056-24-000053.md) | [15.1 d](/filings/0001628280-26-016395.md) | [15.8](/filings/0001628280-25-023137.md) | [17.2](/filings/0001628280-25-038603.md) | [17.8](/filings/0001628280-25-049877.md) | [18.5 d](/filings/0001628280-26-016395.md) | [19.3](/filings/0001628280-26-029797.md) | [23.0](/filings/0001628280-26-051818.md) | [23.1](/filings/0001628280-25-049877.md) | [23.4 d](/filings/0001628280-26-016395.md) | [23.5](/filings/0001628280-26-029797.md) | [26.8](/filings/0001628280-26-051818.md) |
| Research and development | $m | [9.6](/filings/0001462056-24-000053.md) | [9.4 d](/filings/0001628280-26-016395.md) | [9.7](/filings/0001628280-25-023137.md) | [9.6](/filings/0001628280-25-038603.md) | [10.7](/filings/0001628280-25-049877.md) | [12.0 d](/filings/0001628280-26-016395.md) | [11.9](/filings/0001628280-26-029797.md) | [11.9](/filings/0001628280-26-051818.md) | [11.2](/filings/0001628280-25-049877.md) | [11.1 d](/filings/0001628280-26-016395.md) | [11.3](/filings/0001628280-26-029797.md) | [11.0](/filings/0001628280-26-051818.md) |
| Operating income | $m | [(15.6)](/filings/0001462056-24-000053.md) | [(11.6) d](/filings/0001628280-26-016395.md) | [(10.5)](/filings/0001628280-25-023137.md) | [(9.8)](/filings/0001628280-25-038603.md) | [(12.2)](/filings/0001628280-25-049877.md) | [(13.8) d](/filings/0001628280-26-016395.md) | [(8.8)](/filings/0001628280-26-029797.md) | [(6.2)](/filings/0001628280-26-051818.md) | [(3.3)](/filings/0001628280-25-049877.md) | [(4.7) d](/filings/0001628280-26-016395.md) | [(5.4)](/filings/0001628280-26-029797.md) | [(4.2)](/filings/0001628280-26-051818.md) |
| Interest expense | $m | [0.9](/filings/0001462056-23-000207.md) | [1.0 d](/filings/0001462056-24-000033.md) | [0.9](/filings/0001462056-24-000041.md) | [0.9](/filings/0001628280-25-038603.md) | [0.9](/filings/0001628280-25-049877.md) | [1.0 d](/filings/0001628280-26-016395.md) | [0.9](/filings/0001628280-26-029797.md) | [0.9](/filings/0001628280-26-051818.md) | [0.9](/filings/0001628280-25-049877.md) | [1.2 d](/filings/0001628280-26-016395.md) | [1.2](/filings/0001628280-26-029797.md) | [1.3](/filings/0001628280-26-051818.md) |
| Income tax | $m | [0.0](/filings/0001462056-24-000053.md) | [0.0 d](/filings/0001628280-26-016395.md) | [0.0](/filings/0001628280-25-023137.md) | [0.0](/filings/0001628280-25-038603.md) | [0.0](/filings/0001628280-25-049877.md) | [0.0 d](/filings/0001628280-26-016395.md) | [0.1](/filings/0001628280-26-029797.md) | [0.0](/filings/0001628280-26-051818.md) | [0.0](/filings/0001628280-25-049877.md) | [0.0 d](/filings/0001628280-26-016395.md) | [0.0](/filings/0001628280-26-029797.md) | [0.0](/filings/0001628280-26-051818.md) |
| Net income | $m | [(16.1)](/filings/0001462056-24-000053.md) | [(12.2) d](/filings/0001628280-26-016395.md) | [(11.1)](/filings/0001628280-25-023137.md) | [(10.3)](/filings/0001628280-25-038603.md) | [(12.8)](/filings/0001628280-25-049877.md) | [(14.4) d](/filings/0001628280-26-016395.md) | [(9.3)](/filings/0001628280-26-029797.md) | [(7.1)](/filings/0001628280-26-051818.md) | [(3.8)](/filings/0001628280-25-049877.md) | [(5.4) d](/filings/0001628280-26-016395.md) | [(6.1)](/filings/0001628280-26-029797.md) | [(5.1)](/filings/0001628280-26-051818.md) |
| Diluted EPS | $ per share | [(0.44)](/filings/0001462056-24-000053.md) | not reported | [(0.27)](/filings/0001628280-25-023137.md) | [(0.25)](/filings/0001628280-25-038603.md) | [(0.29)](/filings/0001628280-25-049877.md) | not reported | [(0.17)](/filings/0001628280-26-029797.md) | [(0.13)](/filings/0001628280-26-051818.md) | [(0.07)](/filings/0001628280-25-049877.md) | not reported | [(0.10)](/filings/0001628280-26-029797.md) | [(0.08)](/filings/0001628280-26-051818.md) |
| Basic EPS | $ per share | [(0.44)](/filings/0001462056-24-000053.md) | not reported | [(0.27)](/filings/0001628280-25-023137.md) | [(0.25)](/filings/0001628280-25-038603.md) | [(0.29)](/filings/0001628280-25-049877.md) | not reported | [(0.17)](/filings/0001628280-26-029797.md) | [(0.13)](/filings/0001628280-26-051818.md) | [(0.07)](/filings/0001628280-25-049877.md) | not reported | [(0.10)](/filings/0001628280-26-029797.md) | [(0.08)](/filings/0001628280-26-051818.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [9.0](/filings/0001462056-23-000207.md) | [12.5](/filings/0001628280-26-016395.md) | [6.3](/filings/0001628280-25-023137.md) | [9.3](/filings/0001628280-25-038603.md) | [3.0](/filings/0001628280-25-049877.md) | [45.8](/filings/0001628280-26-016395.md) | [40.6](/filings/0001628280-25-023137.md) | [32.2](/filings/0001628280-25-038603.md) | [29.1](/filings/0001628280-25-049877.md) | [29.2](/filings/0001628280-26-051818.md) | [26.3](/filings/0001628280-26-029797.md) | [32.4](/filings/0001628280-26-051818.md) |
| Current assets | $m | [44.9](/filings/0001462056-23-000207.md) | [38.5](/filings/0001462056-25-000015.md) | [38.7](/filings/0001462056-24-000041.md) | [33.7](/filings/0001628280-24-036136.md) | [31.9](/filings/0001462056-24-000053.md) | [65.7](/filings/0001628280-26-016395.md) | [65.0](/filings/0001628280-25-023137.md) | [64.5](/filings/0001628280-25-038603.md) | [65.0](/filings/0001628280-25-049877.md) | [65.7](/filings/0001628280-26-051818.md) | [62.8](/filings/0001628280-26-029797.md) | [68.7](/filings/0001628280-26-051818.md) |
| Total assets | $m | [135](/filings/0001462056-23-000207.md) | [132](/filings/0001462056-25-000015.md) | [132](/filings/0001462056-24-000041.md) | [128](/filings/0001628280-24-036136.md) | [136](/filings/0001462056-24-000053.md) | [169](/filings/0001628280-26-016395.md) | [170](/filings/0001628280-25-023137.md) | [186](/filings/0001628280-25-038603.md) | [192](/filings/0001628280-25-049877.md) | [192](/filings/0001628280-26-051818.md) | [193](/filings/0001628280-26-029797.md) | [224](/filings/0001628280-26-051818.md) |
| Current liabilities | $m | [61.0](/filings/0001462056-23-000207.md) | [57.1](/filings/0001462056-25-000015.md) | [55.7](/filings/0001462056-24-000041.md) | [55.1](/filings/0001628280-24-036136.md) | [59.2](/filings/0001462056-24-000053.md) | [59.8](/filings/0001628280-26-016395.md) | [59.5](/filings/0001628280-25-023137.md) | [59.9](/filings/0001628280-25-038603.md) | [59.3](/filings/0001628280-25-049877.md) | [61.6](/filings/0001628280-26-051818.md) | [59.9](/filings/0001628280-26-029797.md) | [68.8](/filings/0001628280-26-051818.md) |
| Total liabilities | $m | [87.4](/filings/0001462056-23-000207.md) | [86.7](/filings/0001462056-25-000015.md) | [84.4](/filings/0001462056-24-000041.md) | [82.7](/filings/0001628280-24-036136.md) | [93.4](/filings/0001462056-24-000053.md) | [90.9](/filings/0001628280-26-016395.md) | [92.4](/filings/0001628280-25-023137.md) | [106](/filings/0001628280-25-038603.md) | [109](/filings/0001628280-25-049877.md) | [109](/filings/0001628280-26-051818.md) | [108](/filings/0001628280-26-029797.md) | [135](/filings/0001628280-26-051818.md) |
| Current portion of debt | $m | [6.1](/filings/0001462056-23-000207.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [47.4](/filings/0001462056-24-000053.md) | [44.9](/filings/0001628280-26-016395.md) | [47.5](/filings/0001628280-25-038603.md) | [45.1](/filings/0001628280-25-049877.md) | [42.8](/filings/0001628280-25-049877.md) | [77.6](/filings/0001628280-26-051818.md) | [77.8](/filings/0001628280-26-051818.md) | [79.6](/filings/0001628280-26-051818.md) | [82.8](/filings/0001628280-25-049877.md) | [83.2](/filings/0001628280-26-051818.md) | [84.6](/filings/0001628280-26-051818.md) | [88.5](/filings/0001628280-26-051818.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(0.2) d](/filings/0001462056-24-000053.md) | [3.2 d](/filings/0001628280-26-016395.md) | [3.4](/filings/0001628280-25-023137.md) | [2.2 d](/filings/0001628280-25-038603.md) | [4.6 d](/filings/0001628280-25-049877.md) | [2.2 d](/filings/0001628280-26-016395.md) | [4.9](/filings/0001628280-26-029797.md) | [3.5 d](/filings/0001628280-26-051818.md) | [5.7 d](/filings/0001628280-25-049877.md) | [9.3 d](/filings/0001628280-26-016395.md) | [3.4](/filings/0001628280-26-029797.md) | [10.4 d](/filings/0001628280-26-051818.md) |
| Capital expenditure | $m | [0.3 d](/filings/0001462056-24-000053.md) | [0.4 d](/filings/0001628280-26-016395.md) | [0.4](/filings/0001628280-25-023137.md) | [0.3 d](/filings/0001628280-25-038603.md) | [0.2 d](/filings/0001628280-25-049877.md) | [0.8 d](/filings/0001628280-26-016395.md) | [0.5](/filings/0001628280-26-029797.md) | [0.8 d](/filings/0001628280-26-051818.md) | [3.1 d](/filings/0001628280-25-049877.md) | [0.3 d](/filings/0001628280-26-016395.md) | [0.7](/filings/0001628280-26-029797.md) | [0.8 d](/filings/0001628280-26-051818.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001628280-26-016395.md) | [0.0](/filings/0001628280-26-029797.md) | [0.0 d](/filings/0001628280-26-051818.md) | [1.2 d](/filings/0001628280-25-049877.md) | [0.8 d](/filings/0001628280-26-016395.md) | [0.8](/filings/0001628280-26-029797.md) | [0.6 d](/filings/0001628280-26-051818.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [32.0](/filings/0001462056-23-000207.md) | [33.9](/filings/0001462056-24-000041.md) | [35.1](/filings/0001628280-24-036136.md) | [36.7](/filings/0001462056-24-000053.md) | [40.2](/filings/0001628280-25-023137.md) | [42.2](/filings/0001628280-25-038603.md) | [43.5](/filings/0001628280-25-049877.md) | [54.1](/filings/0001628280-26-029797.md) | [55.6](/filings/0001628280-26-051818.md) | [57.0](/filings/0001628280-25-049877.md) | [59.3](/filings/0001628280-26-029797.md) | [60.8](/filings/0001628280-26-051818.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 61,900,000 at 2026-07-27, from the cover of the [10-Q filed 2026-08-03](/filings/0001628280-26-051818.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.